Acquired Genomic Alterations on First-Line Chemotherapy With Cetuximab in Advanced Colorectal Cancer: Circulating Tumor DNA Analysis of the CALGB/SWOG-80405 Trial (Alliance)
      QxMD      Google Scholar   
Citation:
J Clin Oncol vol 41 (3) 472-478
Year:
2023
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
Alliance-data-source,-external-user
Status:
Presented/Published
Citation Status:
pmc-release
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Book Volume:
12
Parents:
3678  
Children:
None
Program:
TRP
Primary Committee:
Correl Sci NOS
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, UG1CA180830, UG1CA233329, U10CA180888 (SWOG)  
Corr. Author:
 
Authors:
               
Networks:
CA011, CA136, LAPS-MN026, LAPS-NC007, LAPS-TX035   
Study
Alliance-A151901
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-80405
Phases:
N/A, 3
Keywords:
CLINICAL TRIAL UPDATES, Gastrointestinal Cancer